Avi Eliassaf
Directeur des opérations chez Anima Biotech, Inc.
Profil
Avi Eliassaf is currently the Chief Operating Officer at Anima Biotech, Inc. Previously, he worked as the Chief Financial Officer at SalesPredict SW Ltd.
He completed his undergraduate degree at Ben-Gurion University of the Negev.
Postes actifs de Avi Eliassaf
| Sociétés | Poste | Début |
|---|---|---|
Anima Biotech, Inc.
 Anima Biotech, Inc. Pharmaceuticals: MajorHealth Technology Anima Biotech, Inc. develops translation control therapeutics, a new class of drugs that specifically control protein translation as a novel strategy against hard and undruggable targets. The firm?s platform combines new biology with proprietory image analysis and big data software. The company was founded Yochi Slonim and Zeev Smilansky and is headquartered in Bernardsville, NJ. | Directeur des opérations | - |
Anciens postes connus de Avi Eliassaf
| Sociétés | Poste | Fin |
|---|---|---|
SalesPredict SW Ltd.
 SalesPredict SW Ltd. Electronics DistributorsDistribution Services SalesPredict SW Ltd. developed predictive analytics solutions. The firm offered solution for marketing, sale and customer management. The company was founded by Yaron Zakai-Or and Kira Radinsky in 2012 and was headquartered in Netanya, Israel. | Directeur Financier/CFO | - |
Formation de Avi Eliassaf
| Ben-Gurion University of the Negev | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
SalesPredict SW Ltd.
SalesPredict SW Ltd. Electronics DistributorsDistribution Services SalesPredict SW Ltd. developed predictive analytics solutions. The firm offered solution for marketing, sale and customer management. The company was founded by Yaron Zakai-Or and Kira Radinsky in 2012 and was headquartered in Netanya, Israel. | Distribution Services |
Anima Biotech, Inc.
Anima Biotech, Inc. Pharmaceuticals: MajorHealth Technology Anima Biotech, Inc. develops translation control therapeutics, a new class of drugs that specifically control protein translation as a novel strategy against hard and undruggable targets. The firm?s platform combines new biology with proprietory image analysis and big data software. The company was founded Yochi Slonim and Zeev Smilansky and is headquartered in Bernardsville, NJ. | Health Technology |
